Uploaded November 2025 | Updated September 2026, 2 weeks ago
Join Ian Khan, the Futurist, at HLTH2026 as he sits down with Michelle, co‑founder of Previvor Edge, a pioneering clinical program in cancer prevention and early detection, covered by insurance.
In this episode, Michelle shares how Previvor Edge helps people understand their unique cancer risk—using genetics, family history, lifestyle, and environmental factors—to create an action plan that can reduce cancer incidence and improve outcomes. Learn why 40% of individuals will be diagnosed with cancer in their lifetime, how early detection and preventive action matter, and how Previvor Edge marries standard‑of‑care screening with emerging tools like multi‑cancer detection tests and full‑body MRI for those who opt‑in.
Michelle is co‑founder and CEO of Previvor Edge, a personalized cancer prevention and early‑detection clinical program that helps individuals assess their unique risk profiles—based on genetics, clinical history, lifestyle, and environment—and guides them with tailored action plans for screening, prevention, and emerging diagnostic technologies, all covered by insurance. With years of experience in the cancer genetics and early detection space, Michelle set out to shift the paradigm from reactive cancer care to proactive prevention and detection.
🔗 Stay Connected:
Buy a Copy of My New Book UNDUSRUPTED amzn.to/4g5gjH9
Visit my website: iankhan.com
Follow me on Twitter: twitter.com/IanKhanFuturist
Follow me on LinkedIn: linkedin.com/in/iankhanfuturist
Follow me on Facebook: facebook.com/iankhanfuturist
Join Ian Khan, the Futurist, at HLTH2026 as he sits down with Michelle, co‑founder of Previvor Edge, a pioneering clinical program in cancer prevention and early detection, covered by insurance.
In this episode, Michelle shares how Previvor Edge helps people understand their unique cancer risk—using genetics, family history, lifestyle, and environmental factors—to create an action plan that can reduce cancer incidence and improve outcomes. Learn why 40% of individuals will be diagnosed with cancer in their lifetime, how early detection and preventive action matter, and how Previvor Edge marries standard‑of‑care screening with emerging tools like multi‑cancer detection tests and full‑body MRI for those who opt‑in.
Michelle is co‑founder and CEO of Previvor Edge, a personalized cancer prevention and early‑detection clinical program that helps individuals assess their unique risk profiles—based on genetics, clinical history, lifestyle, and environment—and guides them with tailored action plans for screening, prevention, and emerging diagnostic technologies, all covered by insurance. With years of experience in the cancer genetics and early detection space, Michelle set out to shift the paradigm from reactive cancer care to proactive prevention and detection.
🔗 Stay Connected:
Buy a Copy of My New Book UNDUSRUPTED amzn.to/4g5gjH9
Visit my website: iankhan.com
Follow me on Twitter: twitter.com/IanKhanFuturist
Follow me on LinkedIn: linkedin.com/in/iankhanfuturist
Follow me on Facebook: facebook.com/iankhanfuturist
